Information Provided By: 
Fly News Breaks for April 21, 2016
STJ
Apr 21, 2016 | 09:15 EDT
Needham analyst Mike Matson raised his price target for St. Jude Medical to $75 from $70 following better-than-expected Q1 results. The analyst believes that the company's revenue growth has bottomed and expects it to accelerate over the next 12 months as St. Jude Medical launches a number of other new products. Matson reiterates a Strong Buy rating on the shares.
News For STJ From the Last 2 Days
There are no results for your query STJ
